StreetAlpha.app
Home › Stocks › AXGN

Axogen, Inc. (AXGN)

Healthcare
$55.37
▼ −0.02%
LAST CLOSE · NOV 17

Axogen makes products for peripheral nerve repair, sold to surgeons and other healthcare providers. It last closed at $55.37 on Nov 17, down 0.02% on the day. The average 12-month price target from 8 analysts is $56.63 (+2.3% from the last close), with a high of $60.00 and a low of $52.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (8 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in AXGN, 75% of them bullish and 25% bearish.

AI Auto Pilots
Is AXGN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$266.9M
+24.3% vs a year ago
Net income
−$31.9M
−12.0% margin
EPS (diluted)
−$0.63
Free cash flow
$22.0M
8.3% margin
Valuation
Market cap
$3.3B
59.7M shares
P/E
–
No P/E while losing money
Price to sales
12.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$328.9M
At Sep 30
Debt
$0
At Sep 30
Shareholder equity
$496.1M
Shares outstanding
59.7M
At Oct 26
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $127.4M$127.4MFY2021FY2022: $138.6M$138.6MFY2022FY2023: $159.0M$159.0MFY2023FY2024: $187.3M$187.3MFY2024FY2025: $225.2M$225.2MFY2025

From AXGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 28). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 8 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
8firms
8 Buy0 Hold0 Sell
Each firm's latest rating on AXGN in the past 90 days
Average 12-month target
$56.63
▲ 2.3% upside

Based on 8 analysts who set a price target on AXGN in the past 90 days. The average target is $56.63, with a high of $60.00 and a low of $52.00, compared with the last close of $55.37.

Low $52.00Avg $56.63High $60.00
Blue marker: last close $55.37
Highest target$60.00
Average target$56.63
Lowest target$52.00
Latest rating changes
Canaccord GenuityTarget raised
Oct 29Buy$55 → $60
Leerink PartnersMaintained
Oct 29Buy$56
BarclaysTarget raised
Oct 29Buy$50 → $60
Truist SecuritiesTarget raised
Oct 29Buy$53 → $60
Wells FargoMaintained
Oct 29Buy$56
DateFirmActionRatingPrice target
Oct 29Canaccord GenuityTarget raisedBuy$55 → $60
Oct 29Leerink PartnersMaintainedBuy$56
Oct 29BarclaysTarget raisedBuy$50 → $60
Oct 29Truist SecuritiesTarget raisedBuy$53 → $60
Oct 29Wells FargoMaintainedBuy$56
Loading…

Technical Analysis

AXGN · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 13% above its 20 day and 21% above its 50 day average. It is 26% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 68), near overbought. The nearest support is the Pivot S1 at $54.45, and the nearest resistance the Pivot at $55.66.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 5.0%/day
Key levels
$59.7252 week high+7.9%
$59.72Swing high (Nov 11)+7.9%
$56.58Pivot R1+2.2%
$55.66Pivot+0.5%
$55.37Last close
$54.45Pivot S1−1.7%
$48.3320 day average−12.7%
$47.56Swing low (Nov 5)−14.1%
$44.41100 day average−19.8%
$43.5850 day average−21.3%
$40.73200 day average−26.4%
$23.0052 week low−58.5%
Indicators
RSI (14)68.23Strong, overbought above 70Neutral
MACD4.02Above its signal lineBullish
Stochastic73.6Middle of its rangeNeutral
ADX (14)44.9Strong uptrend
Williams %R-35.8Oversold below −80, overbought above −20Neutral
CCI (20)91.5Oversold below −100, overbought above 100Neutral
Rate of change+11.9%Change over 10 sessionsBullish
ATR (14)$2.77Typical daily range, 5.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AXGN

What happened before

See how AXGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish3 bullish and 1 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow AXGN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How AXGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
4
Bullish
3
75%
Bearish
1
25%
Date span
Sep 24 – Oct 28
Loading…

See today’s whale options flow across the market →

AXGN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●134 buying vs 123 selling
  • ▲Held by funds +9.2 pts
  • ●Funds holding -2
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding253255−0.8%
In funds' top 1056−16.7%
Held by funds99.8%90.6%+9.2 pts
New / increased36 / 9850 / 111−16.8%
Reduced / sold out83 / 4064 / 19+48.2%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AXGN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AXGN is in one of them and how their past AXGN trades turned out.

AXGN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AXGN in an article yet. Here's the latest on the wider market.

AXGN Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 27
Who traded AXGN · since 2019
Latest 2 filings
$1K – $15KTraded Jun 24, 2019Filed Apr 27, 2020
$1K – $15KTraded Apr 16, 2019Filed Apr 27, 2020
PersonTypeAmountTradedFiledDelay
Donna ShalalaD · FLSell$1K – $15KJun 24, 2019Apr 27, 2020308 d
Donna ShalalaD · FLBuy$1K – $15KApr 16, 2019Apr 27, 2020377 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Axogen

Axogen is based in Alachua, Florida, and develops and sells products for repairing peripheral nerves, the pathways that carry movement and sensation signals throughout the body. Its main offerings include nerve grafts for bridging severed nerves, nerve connectors and protectors made from pig tissue, and a soft tissue matrix made from amniotic membrane. Surgeons and other healthcare providers use these products in surgeries to treat traumatic injuries, dental and orthopedic procedures, and breast reconstruction. Its products are sold mainly in the United States, with sales also in Canada, Germany, the United Kingdom, Spain and several other countries.

Headquarters
Alachua, FL